Multicenter clinical study of Yiqi tongluo decoction in prevention and treatment of restenosis after stenting in patients with acute coronary syndrome

Shanghai Municipal Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) All patients were clinically diagnosed with acute coronary syndrome, including unstable angina, ST-elevation myocardial infarction and non-ST-elevation myocardial infarction, followed by coronary intervention with at least one stent;
•(2) Within one month of Stenting, age 40-80 years old, sex is not limited;
•(3) The Syndrome of Qi deficiency and blood stasis;
•(4) The patient and the family are willing to cooperate and meet the exclusion criteria.

•(1) Patients with cardiac function grade 4 or Pulmonary Edema;
•(2) Patients with severe primary brain, lung disease and hepatic and renal dysfunction;
•(3) Patients with allergic reaction to traditional Chinese medicine;
•(4) Patients with malignant disease;
•(5) Patients with severe inflammatory disease;
•(6) Patients with hemorrhagic disease;
•(7) Patients with Malignant Arrhythmia;
•(8) Mentally ill;
•(9) Pregnant or lactating women;
•(10) Enrolled in its clinical trial within 1 month.

发起方